http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20110012608-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a6a0833d7d1f9d2a9cdb7e2bcb46f0e1
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2095
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-439
filingDate 2009-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_57fe01abfda1425031e53b11e6480a3f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_077b13ce7573ea37f0054bb2442bce97
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ccda0a03be78eac91541101a47c741c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c3f1d8f2b32e454505e1f3ef89e272f
publicationDate 2011-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-20110012608-A
titleOfInvention Oral disintegrating tablet of granisetron and preparation method thereof
abstract The present invention relates to an orally disintegrating tablet (ODT) and a method for preparing the same, comprising granisetron or a pharmaceutically acceptable salt thereof, wherein the orally disintegrating tablet according to the present invention is in vitro. In-vitro disintegration time of less than 30 seconds not only disintegrates rapidly in the oral cavity, but also masks the unique bitter taste of Granissetron, so that patients with swallowing disorders, especially those undergoing long-term chemotherapy, can be taken without water. In order to improve compliance, it does not require expensive equipment, and can be mass-produced in an economical and convenient way.n n n Granisetron, Oral Disintegrating Tablet, Medication Compliance
priorityDate 2009-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24261
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4595
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453441434
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453754419
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID294739
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID294739
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6251
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534943
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23665634
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6917
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID442089
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID151263
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527835
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415853316
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398745
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452788844
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507378
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID59774
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154497524
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419551217
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433323517
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457707758
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534805
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506927
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284566
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62223

Total number of triples: 46.